Purple Biotech Unveils CAPTN-3 Platform Data
Ticker: PPBT · Form: 6-K · Filed: Apr 27, 2026 · CIK: 0001614744
| Field | Detail |
|---|---|
| Company | Purple Biotech Ltd. (PPBT) |
| Form Type | 6-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: biotech, drug-development, data-announcement, foreign-issuer
TL;DR
Purple Biotech dropped new CAPTN-3 data for IM1240 today. Check it out.
AI Summary
Purple Biotech Ltd. announced new data from its CAPTN-3 platform for its tri-specific IM1240 on April 27, 2026. The filing is a Form 6-K, indicating it's a report from a foreign private issuer.
Why It Matters
This announcement provides investors with updated information on Purple Biotech's key drug development platform and a specific drug candidate, potentially impacting its valuation.
Risk Assessment
Risk Level: medium — Biotech announcements often carry inherent risks due to the speculative nature of drug development and clinical trial outcomes.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer of the report and developer of the CAPTN-3 platform.
- IM1240 (drug_candidate) — A tri-specific drug candidate developed using the CAPTN-3 platform.
- CAPTN-3 (platform) — The platform used by Purple Biotech for drug development, from which new data was announced.
- 2026-04-27 (date) — The filing date and period of report for this 6-K filing.
FAQ
What specific new data was announced regarding the CAPTN-3 platform and IM1240?
The filing itself does not contain the specific details of the new data; it refers to an exhibit (EX-99.1) which contains the announcement and graphic.
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer that is required to be filed with the SEC to provide information that the issuer publicly discloses or is required to disclose in its home country.
Where is Purple Biotech Ltd. located?
Purple Biotech Ltd. is located at 4 Oppenheimer Street, Science Park, Rehovot, L3 7670104.
What is the SIC code associated with Purple Biotech Ltd.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was this filing accepted by the SEC?
This filing was accepted by the SEC on 2026-04-27 at 07:15:16.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 27, 2026 regarding PURPLE BIOTECH LTD. (PPBT).